Clinical Trial: A Study to Learn About COVID-19 Antivirals in People With SARS-CoV-2 Infection From 2023-2026

U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07900139) titled 'A Study to Learn About COVID-19 Antivirals in People With SARS-CoV-2 Infection From 2023-2026' on Oct. 21.

Brief Summary: The purpose of this study is to learn about the management, treatment, healthcare resource utilization (HCRU), and outcomes of individuals with SARS-CoV-2 infection.

This is a retrospective secondary analysis of administrative claims data from 2023-2026, therefore there is no enrollment or participation required. The study will describe and evaluate the real-world management, treatment, HCRU, and outcomes of individuals with SARS-CoV-2 infection.

Study Start Date: July 20

Study Type: OBSERVATIONAL

Condition: ...